메뉴 건너뛰기




Volumn 17, Issue 6, 2001, Pages 167-182

Enzymatic synthesis of chiral intermediates for Omapatrilat, an antihypertensive drug

Author keywords

Chiral intermediates; Enzymatic synthesis; Omapatrilat

Indexed keywords

OMAPATRILAT; PLASMID VECTOR; PRODRUG;

EID: 0035025463     PISSN: 13890344     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1389-0344(01)00068-5     Document Type: Review
Times cited : (81)

References (50)
  • 1
    • 0004929505 scopus 로고    scopus 로고
    • Food & Drug Administration. FDA's statement for the development of new stereoisomeric drugs. Chirality, 1992;4:338-340.
  • 2
    • 0004956533 scopus 로고    scopus 로고
    • Borman S. FDA issues flexible policy on chiral drugs. Chem Eng News 1992; June 17, p 5.
  • 16
    • 0004934863 scopus 로고    scopus 로고
    • Patel R. (Ed.), Stereoselective biocatalysis, New York: Marcel Dekker
    • (1999) , pp. 87-130
    • Patel, R.N.1
  • 17
    • 0004956534 scopus 로고    scopus 로고
    • Mori K. Synlett. 1995; 1097-1109.
  • 18
    • 0004967542 scopus 로고
    • Enzymes in synthetic organic chemistry. Tetrahedron Organic Chemistry Series, New York: Elsevier
    • (1994) , vol.12
    • Wong, C.H.1    Whitesides, G.M.2
  • 43
    • 0004928970 scopus 로고    scopus 로고
    • Hanson R, Donovan M, Nanduri VK, Ramig K, Swaminathan S, Rosso V, Lust D, Tse K, Venit J, Szarka L, Patel RN. US Patent Appl # HA 690.
  • 45
    • 0000980630 scopus 로고
    • Collins A.N., Sheldrake G.N., Crosby J. (Eds.), Chirality in industry, New York: Wiley
    • (1992) , pp. 209-222
    • Stirling, D.I.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.